Imjudo (Tremelimumab) is a CTLA-4 inhibitor used in combination with durvalumab to treat unresectable hepatocellular carcinoma and non-small cell lung cancer. Given as an intravenous infusion. Supplied by A.K. Pharma — trusted cancer medicine wholesaler in Delhi.